SEC Filing Summary: cbdMD, Inc. (8-K)
Business Context and Reporting Period
This Form 8-K was filed by cbdMD, Inc. on August 20, 2019. The registrant is an emerging growth company incorporated in North Carolina, with its principal executive offices in Charlotte, NC. The company's common stock trades on the NYSE American under the symbol YCBD.
Key Financial Metrics
The filing text does not provide specific financial values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves as a disclosure vehicle for an investor presentation rather than a financial statement itself.
Material Changes
The filing references an updated investor relations presentation released on August 20, 2019. This presentation reflects business updates consistent with the Form 10-Q for the period ended June 30, 2019, which was filed on August 14, 2019. No specific quantitative changes are detailed within this 8-K text.
Guidance, Outlook, and Risks
Management commentary and business outlook are contained within the furnished Exhibit 99.1 (Investor Relations Presentation). The filing explicitly states that the information in Item 7.01 and Exhibit 99.1 is furnished and not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor is it incorporated by reference into other filings.
Investor Verification Checklist
- Review the Form 10-Q filed on August 14, 2019, for the detailed financial data referenced in this report.
- Examine Exhibit 99.1 (Investor Relations Presentation) for the specific business updates and management commentary.
- Note that the information in this 8-K is not incorporated by reference into other SEC filings.
- Verify the company's status as an emerging growth company and its election regarding extended transition periods for accounting standards.